Ignite Creation Date:
2024-05-06 @ 6:25 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05656274
Status:
RECRUITING
Last Update Posted:
2022-12-19
First Post:
2022-12-09
Brief Title:
A Study of the SafetyTolerabilityand Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects
Sponsor:
Tasly Pharmaceutical Group Co Ltd
Organization:
Tasly Pharmaceutical Group Co Ltd
Study Overview
Official Title:
A Phase 1bRandomized InvestigatorParticipant-Blind Placebo-Controlled Multiple-Ascending Dose Trial to Evaluate the Safety Tolerance and Pharmacokinetics of JS1-1-01 in Healthy Subjects
Status:
RECRUITING
Status Verified Date:
2022-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safetytolerabilityand pharmacokinetics of multiple-accending dose of JS1-1-01
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None